Zimmer Biomet Holdings Stock Today
| ZBH Stock | USD 119.33 1.97 1.62% |
Performance0 of 100
| Odds Of DistressLess than 6
|
Zimmer Biomet is trading at 119.33 as of the 18th of April 2024. This is a -1.62 percent down since the beginning of the trading day. The stock's open price was 121.3. Zimmer Biomet has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Zimmer Biomet Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of May 2023 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of July 2001 | Category Healthcare | Classification Health Care |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. The company has 205.46 M outstanding shares of which 4.73 M shares are at this time shorted by investors with about 3.67 days to cover. More on Zimmer Biomet Holdings
Moving together with Zimmer Stock
| 0.74 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
Moving against Zimmer Stock
| 0.58 | IVP | Inspire Veterinary | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 7th of May 2024
Zimmer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zimmer Biomet's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zimmer Biomet or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Zimmer Biomet's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zimmer Biomet's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO and President and Director | David Dvorak | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Zimmer Biomet Holdings Inc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Medical Equipment, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Zimmer Biomet report their recommendations after researching Zimmer Biomet's financial statements, talking to executives and customers, or listening in on Zimmer Biomet's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Zimmer Biomet Holdings. The Zimmer consensus assessment is calculated by taking the average forecast from all of the analysts covering Zimmer Biomet. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Zimmer Biomet's liquidity, profitability, solvency, and operating efficiency, Zimmer Biomet Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Zimmer Biomet Holdings is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zimmer Biomet's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zimmer Biomet's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Zimmer Biomet's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Zimmer Biomet's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zimmer Biomet's financial leverage. It provides some insight into what part of Zimmer Biomet's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zimmer Biomet Holdings (ZBH) is traded on New York Stock Exchange in USA. It is located in 345 East Main Street, Warsaw, IN, United States, 46580 and employs 18,000 people. Zimmer Biomet is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 25.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zimmer Biomet's market, we take the total number of its shares issued and multiply it by Zimmer Biomet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zimmer Biomet Holdings runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 205.46 M outstanding shares of which 4.73 M shares are at this time shorted by investors with about 3.67 days to cover.
Zimmer Biomet Holdings has about 375.7 M in cash with 1.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.71.
Check Zimmer Biomet Probability Of Bankruptcy
Ownership AllocationZimmer Biomet Holdings retains a total of 205.46 Million outstanding shares. The majority of Zimmer Biomet outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zimmer Biomet Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zimmer Biomet Holdings. Please pay attention to any change in the institutional holdings of Zimmer Biomet Holdings as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zimmer Ownership Details
Zimmer Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Zimmer Biomet jumping above the current price in 90 days from now is about 99.0%. The Zimmer Biomet Holdings probability density function shows the probability of Zimmer Biomet stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Zimmer Biomet has a beta of 0.9715. This usually means Zimmer Biomet Holdings market returns are responsive to returns on the market. As the market goes up or down, Zimmer Biomet is expected to follow. Additionally, zimmer Biomet Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Zimmer Biomet to move above the current price in 90 days from now is about 99.0 (This Zimmer Biomet Holdings probability density function shows the probability of Zimmer Stock to fall within a particular range of prices over 90 days) .
Zimmer Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Zimmer Biomet that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zimmer Biomet's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zimmer Biomet's value.| Instituion | Recorded On | Shares | |
| Victory Capital Management Inc. | 2023-12-31 | 3.2 M | |
| Van Eck Associates Corporation | 2023-12-31 | 2.8 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.8 M | |
| Allspring Global Investments Holdings, Llc | 2023-12-31 | 2.8 M | |
| Boston Partners Global Investors, Inc | 2023-12-31 | 2.6 M | |
| Northern Trust Corp | 2023-12-31 | 2.5 M | |
| Norges Bank | 2023-12-31 | 2.2 M | |
| Neuberger Berman Group Llc | 2023-12-31 | 2.2 M | |
| Legal & General Group Plc | 2023-12-31 | 2.1 M | |
| Vanguard Group Inc | 2023-12-31 | 23.9 M | |
| Blackrock Inc | 2023-12-31 | 18.7 M |
Zimmer Biomet Historical Income Statement
Zimmer Biomet Holdings Income Statement is one of the three primary financial statements used for reporting Zimmer's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zimmer Biomet Holdings revenue and expense. Zimmer Biomet Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Zimmer Biomet's Tax Provision is increasing as compared to previous years. View More FundamentalsZimmer Stock Against Markets
Picking the right benchmark for Zimmer Biomet stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Zimmer Biomet stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Zimmer Biomet is critical whether you are bullish or bearish towards Zimmer Biomet Holdings at a given time. Please also check how Zimmer Biomet's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zimmer Biomet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Zimmer Biomet Corporate Directors
Zimmer Biomet corporate directors refer to members of a Zimmer Biomet board of directors. The board of directors generally takes responsibility for the Zimmer Biomet's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zimmer Biomet's board members must vote for the resolution. The Zimmer Biomet board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Arthur Higgins | Independent Director | Profile | |
| Michael Michelson | Independent Director | Profile | |
| Cecil Pickett | Independent Director | Profile | |
| Jeffrey Rhodes | Director | Profile |
How to buy Zimmer Stock?
Before investing in Zimmer Biomet, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Zimmer Biomet. To buy Zimmer Biomet stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Zimmer Biomet. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Zimmer Biomet stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Zimmer Biomet Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Zimmer Biomet Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Zimmer Biomet Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Zimmer Stock please use our How to Invest in Zimmer Biomet guide.
Already Invested in Zimmer Biomet Holdings?
The danger of trading Zimmer Biomet Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zimmer Biomet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zimmer Biomet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zimmer Biomet Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.96 | Earnings Share 4.88 | Revenue Per Share 35.43 | Quarterly Revenue Growth 0.063 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.